🔗 Visit the ClinicalTrials.gov page for NCT00640978
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. | BMC Cancer | 2010 | 1.36 |
| 2 | Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies. | Ther Adv Med Oncol | 2015 | 1.00 |
| 3 | Role of cancer stem cells in pancreatic ductal adenocarcinoma. | Nat Rev Clin Oncol | 2009 | 0.99 |
| 4 | Current and future systemic treatment options in metastatic pancreatic cancer. | J Gastrointest Oncol | 2014 | 0.95 |